Effects of Medium Cutoff Membranes on Pro-Inflammatory Cytokine and Oxidative Marker Levels in Patients with Sepsis Who Developed Acute Kidney Injury.


Journal

Blood purification
ISSN: 1421-9735
Titre abrégé: Blood Purif
Pays: Switzerland
ID NLM: 8402040

Informations de publication

Date de publication:
2022
Historique:
received: 07 08 2021
accepted: 27 09 2021
pubmed: 24 11 2021
medline: 15 9 2022
entrez: 23 11 2021
Statut: ppublish

Résumé

There is insufficient data on the role of the medium cutoff (MCO) membranes in the clearance of pro-inflammatory cytokines and oxidant radicals in patients with sepsis requiring hemodialysis. The study consisted of 38 septic patients who developed acute kidney injury (AKI) and who were scheduled to undergo 2 sessions of hemodialysis. Nineteen patients underwent their first dialysis session with the MCO membrane and 19 patients with the high-flux (HF) membrane. In the second session, the membranes were switched. Pro-inflammatory cytokine and oxidative marker levels were measured in blood samples obtained before and after both dialysis sessions. Reduction ratios were compared for the 2 types of hemodialysis membranes. After the first session, there was a greater reduction in tumor necrosis factor (TNF)-α with the MCO membrane (28.2 ± 21.1 vs. 8.0 ± 6.6, p = 0.001). After the second session, there was a greater reduction in interleukin (IL)-6 (27.8 ± 26.5 vs. 5.9 ± 13.3, p = 0.003) and IL-1β (20.5 ± 21.1 vs. 4.0 ± 6.5, p = 0.004) with the MCO membrane. When the first and second sessions of all 38 patients were compared, the reductions in TNF-α, IL-6, and IL-1β were consistently greater for MCO than HF (p = 0.001, p = 0.006, p < 0.001, respectively). The reductions in total antioxidant status, total oxidant status, and myeloperoxidase were not statistically different for the 2 types of dialysis membranes. MCO membrane was superior to HF membrane in the removal of cytokines in septic patients with AKI. However, a similar effect was not observed for oxidative stress markers.

Identifiants

pubmed: 34814149
pii: 000519881
doi: 10.1159/000519881
doi:

Substances chimiques

Biomarkers 0
Cytokines 0
Interleukin-6 0
Membranes, Artificial 0
Oxidants 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

772-779

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Mustafa Comoglu (M)

Department of Internal Medicine, Ankara City Hospital, Ankara, Turkey.

Fatih Dede (F)

Department of Nephrology, Ankara City Hospital, Ankara, Turkey.

Ezgi Coskun Yenigun (EC)

Department of Nephrology, Ankara City Hospital, Ankara, Turkey.

Canan Topcuoglu (C)

Department of Biochemistry, Ankara City Hospital, Ankara, Turkey.

Osman Inan (O)

Department of Internal Medicine, Ankara City Hospital, Ankara, Turkey.

Enes Seyda Sahiner (ES)

Department of Internal Medicine, Ankara City Hospital, Ankara, Turkey.

Ihsan Ates (I)

Department of Internal Medicine, Ankara City Hospital, Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH